Finance professor Alan Jagolinzer discusses how biotech executives profit from legal insider trades
Redirecting to:
- Home
- Undergraduate Programs
Undergraduate Programs
Undergraduate ResourcesAreas of StudyEnhance Your Experience - Graduate Programs
Graduate Programs
MBA ProgramsMS Programs and CertificatesMaster's in Analytics - Faculty & Research
Faculty and Research
Faculty DirectoryFaculty Insights- Faculty Insights
- To Succeed in the Workplace, be Humble
- US Companies Have to Start Talking About Climate Change Under New SEC Rule
- Plasma Donations: A Financial Lifesaver and an Ethical Dilemma
- Facts Ignored: The Truth is Flexible When Falsehoods Support Political Beliefs
- How the ‘Blockbuster Effect’ Boosts Some Crowdfunding Campaigns
- Alumni
Alumni
Amplify Leeds StoriesSupport StudentsGive Back - Centers
- News
- About Us